Available from: and OConnor Christina
Adding a fourth receptor target from a different class is reasonable
Rosenstock J, Raccah D, Kornyi L, et al
A significant meta-analysis highlighted GLP-1RAs ability to lower total cholesterol, low-density lipoprotein cholesterol (LDL-C), and triglyceride levels compared to other antidiabetic agents or placebo
To find out more about the formulation, how biotic solutions are becoming the cornerstone of the weight management scene and the molecular mechanisms underlying the nutraceuticals efficacy, NBR caught up with resbiotics founder and CEO, Dr Vivek Lal
As with any medication, adjusting to GLP-1 therapy can come with some side effects, particularly digestive issues like nausea, diarrhea, and constipation